- Home
- ALKS vs PRCT Comparison
ALKS vs PRCT Comparison
Compare ALKS & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALKS
- PRCT
- Stock Information
- Founded
- ALKS 1987
- PRCT 2009
- Country
- ALKS Ireland
- PRCT United States
- Employees
- ALKS N/A
- PRCT N/A
- Industry
- ALKS Biotechnology: Pharmaceutical Preparations
- PRCT Medical Specialities
- Sector
- ALKS Health Care
- PRCT Health Care
- Exchange
- ALKS Nasdaq
- PRCT Nasdaq
- Market Cap
- ALKS 5.7B
- PRCT 4.7B
- IPO Year
- ALKS 1991
- PRCT 2021
- Fundamental
- Price
- ALKS $35.32
- PRCT $62.25
- Analyst Decision
- ALKS Buy
- PRCT Strong Buy
- Analyst Count
- ALKS 12
- PRCT 7
- Target Price
- ALKS $37.25
- PRCT $97.86
- AVG Volume (30 Days)
- ALKS 1.9M
- PRCT 764.2K
- Earning Date
- ALKS 02-12-2025
- PRCT 02-25-2025
- Dividend Yield
- ALKS N/A
- PRCT N/A
- EPS Growth
- ALKS 3.47
- PRCT N/A
- EPS
- ALKS 2.17
- PRCT N/A
- Revenue
- ALKS $1,557,632,000.00
- PRCT $199,843,000.00
- Revenue This Year
- ALKS N/A
- PRCT $67.07
- Revenue Next Year
- ALKS $4.67
- PRCT $40.64
- P/E Ratio
- ALKS $16.28
- PRCT N/A
- Revenue Growth
- ALKS N/A
- PRCT 71.71
- 52 Week Low
- ALKS $22.90
- PRCT $45.20
- 52 Week High
- ALKS $36.45
- PRCT $103.81
- Technical
- Relative Strength Index (RSI)
- ALKS 71.72
- PRCT 29.56
- Support Level
- ALKS $31.01
- PRCT $64.04
- Resistance Level
- ALKS $36.45
- PRCT $68.38
- Average True Range (ATR)
- ALKS 1.05
- PRCT 3.30
- MACD
- ALKS 0.32
- PRCT -0.15
- Stochastic Oscillator
- ALKS 81.57
- PRCT 1.14
About ALKS Alkermes plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
About PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System,, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. The company's assets are based in the United States. Its revenue is generated from sales of the AquaBeam Robotic System and the accompanying single-use disposable handpieces.